ProCE Banner Activity


Medical Minute 1: Clinical Implications of Updated Heart Failure Nomenclature


In this Medical Minute, learn how to apply the updated heart failure nomenclature from the 2022 AHA/ACC guidelines to accurately identify and diagnose patients. 

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

Nurses: 0.25 Nursing contact hour

Released: March 28, 2023

Expiration: March 27, 2024

No longer available for credit.



Lee R. Goldberg

Lee R. Goldberg, MD, MPH, FACC, FAHA, FHFSA

Vice Chair of Medicine for Informatics
Section Chief, Advanced Heart Failure and Cardiac Transplant
Professor of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by an educational grant from

Merck Sharp & Dohme Corp.


Practicing Clinicians Exchange

ProCE Banner

Target Audience

This program is intended for those healthcare professionals who manage patients with heart failure, including cardiology, internal/family medicine physicians, and advanced practice providers (nurse practitioners or physician associates/physician assistants).

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of healthcare professionals who manage patients with HF in the understanding and application of the most recent HF guidelines into patient care.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the clinical implications of the updated HF staging and classification recommendations


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Lee R. Goldberg, MD, MPH, FACC: consultant/advisor/speaker: Abbott, Viscardia, Zoll/Respircardia.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Daniel Thibodeau, DHSc, MPH, PA-C as noted below: 

Daniel Thibodeau, DHSc, MPH, PA-C: consultant/advisor/speaker: Arbor Pharmaceuticals.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from March 28, 2023, through March 27, 2024:

1. Create an account or Login at 
2. Read the target audience, learning objectives, and faculty disclosures
3. View and study the content in its entirety
4. Submit answers to the post-test questions and evaluation questions online 

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by clicking the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.25 contact hours.

Physician Assistants/Physician Associates Continuing Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until March 27, 2024. PAs should only claim credit commensurate with the extent of their participation.